Anticonvulsant activity of a newly synthesized analgesic from the hexaazaisowurtzitanes class. (Experimental study)

Close metadata

OBJECTIVE

To study anticonvulsant activity of thiowurtzine in seizure models induced by pentylenetetrazol and thiosemicarbazide.

MATERIAL AND METHODS

Experiments were conducted on male CD-1 mice. Thiowurtzine was administered intragastrically at doses of 50, 100 and 200 mg/kg. Carbamazepine (100 mg/kg) was used as a reference drug. Anticonvulsant activity was investigated in antagonism tests with pentylenetetrazol (PTZ 140 mg/kg subcutaneously) and thiosemicarbazide (TSC 30 mg/kg subcutaneously). Anticonvulsant activity was assessed considering latency of various seizure stages, their frequency, and animal survival.

RESULTS

In PTZ test, thiowurtzine 100 mg/kg significantly prolonged latent period of myoclonic seizures by 92% and clonic seizures by 95%, as well as survival time by 73% compared to the control group. All changes were significant. Survival reached 41.7% that was comparable to the effect of carbamazepine. At 200 mg/kg, efficacy decreased that indicated a narrow therapeutic window. In TSC model, thiowurtzine did not significantly affect survival. However, dose 100 mg/kg reduced the number of the most severe tonic seizures by 31%.

CONCLUSION

Thiowurtzine possesses anticonvulsant activity, most pronounced in GABA-dependent pentylenetetrazol model. These data indicate membrane-stabilizing effect and expand potentials for this compound in comorbid conditions.

Keywords:

analgesic

hexaazaisowurtzitane

thiowurtzine

anticonvulsant activity

pentylenetetrazol

thiosemicarbazide

Received:

26.02.2026

Accepted:

25.03.2026

List of references:

Mikhaylova AS. Clinician’s analgesic arsenal. Farmateka. 2018;(3):50-56. (In Russ.). https://doi.org/10.18565/pharmateca.2018.s3.50-56
Kulagina DA, Sysolyatin SV, Krylova SG, Kiseleva EA, Povetyeva TN, Zueva EP, Eremina VV, Alekseeva NA, Strokova SV, Suslov NI, Zhdanov VV. Biological Activity of Hexaazaisowurtzitane Derivatives. Molecules. 2023 Dec 14;28(24):8084. PMID: 38138574; PMCID: PMC10745456. https://doi.org/10.3390/molecules28248084
Aguero S, Megy S, Eremina VV, Kalashnikov AI, Krylova SG, Kulagina DA, Lopatina KA, Fournier M, Povetyeva TN, Vorozhtsov AB, Sysolyatin SV, Zhdanov VV, Terreux R. Discovery of a Novel Non-Narcotic Analgesic Derived from the CL-20 Explosive: Synthesis, Pharmacology, and Target Identification of Thiowurtzine, a Potent Inhibitor of the Opioid Receptors and the Ion Channels. ACS Omega. 2021 May 31;6(23):15400-15411. PMID: 34151118; PMCID: PMC8210403. https://doi.org/10.1021/acsomega.1c01786
Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2-S15. https://doi.org/10.1016/j.pain.2010.09.030
Zamponi GW. Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nature Reviews Drug Discovery. 2016;15(1):19-34. https://doi.org/10.1038/nrd.2015.5
Shlobin NA, Sander JW. Learning from the comorbidities of epilepsy. Current Opinion in Neurology. 2022;35(2):175-180. https://doi.org/10.1097/WCO.0000000000001010
Rice ASC, Cimino-Brown D, Eisenach JC, Kontinen VK, Lacroix-Fralish ML, Machin I, Mogil JS, Stöhr T; (on behalf of the Preclinical Pain Consortium). Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards. Pain. 2008 Oct 15;139(2):243-247. Epub 2008 Sep 23. PMID: 18814968. https://doi.org/10.1016/j.pain.2008.08.017
Löscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure. 2011;20(5):359-368. https://doi.org/10.1016/j.seizure.2011.01.003
Mironov AN, ed. Preclinical drug research guide. Part one. Moscow: Grif & K; 2012. (In Russ.).
Vogel HG, ed. Drug Discovery and Evaluation: Pharmacological Assays. 3rd ed. Berlin, Heidelberg: Springer-Verlag; 2008. https://doi.org/10.1007/3-540-29837-1
Lemeshko BYu, Lemeshko SB. Problems of nonparametric goodness-of-fit test application in tasks of measurement results processing. Sistemy analiza i obrabotki dannykh. 2021;2(82):47-66 (In Russ.). https://doi.org/10.17212/2782-2001-2021-2-47-66